NasdaqGM - Delayed Quote USD
Zentalis Pharmaceuticals, Inc. (ZNTL)
At close: October 21 at 4:00 PM EDT
After hours: October 21 at 4:14 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
EPPERLY MELISSA B Chief Financial Officer | Sale | Feb 12, 2024 | 451,449 |
GALLAGHER CAM S President | Sale | May 31, 2024 | 633,680 |
HAUSMAN DIANA Officer | Sale | May 9, 2024 | 373,876 |
JOHNSON DAVID MICHAEL Director | Stock Award(Grant) | Jun 21, 2024 | 192,818 |
KARIUKI ENOCH Director | Stock Award(Grant) | Jun 21, 2024 | 79,762 |
LACKNER MARK Officer | Sale | Feb 2, 2024 | 195,728 |
PAUL ANDREA Officer | Sale | Feb 2, 2024 | 149,973 |
SKVARKA JAN Director | Stock Award(Grant) | Jun 21, 2024 | 89,551 |
VULTAGGIO VINCENT Officer | Sale | Oct 4, 2024 | 33,855 |
WALKER LUKE NATHANIEL Director | Stock Award(Grant) | May 24, 2024 | 72,481 |
Related Tickers
VTYX Ventyx Biosciences, Inc.
2.3900
-5.91%
BDTX Black Diamond Therapeutics, Inc.
3.2100
-3.02%
PRLD Prelude Therapeutics Incorporated
1.7800
-6.32%
PRTG Portage Biotech Inc.
5.83
-4.89%
APLT Applied Therapeutics, Inc.
8.99
+0.33%
RLAY Relay Therapeutics, Inc.
6.43
-4.46%
MNPR Monopar Therapeutics Inc.
5.25
-4.55%
DRMA Dermata Therapeutics, Inc.
1.5600
-3.11%
FDMT 4D Molecular Therapeutics, Inc.
8.58
+0.59%
ORIC ORIC Pharmaceuticals, Inc.
9.12
-3.49%